SIFI announces allowance of patent on polihexanide for Europe and commercial launch of AKANTIOR® in Germany
07.08.2025 - 18:08:41 | prnewswire.co.uk
The company's intellectual property ("IP") covers the formulation and method of use of polihexanide in the treatment of acanthamoeba keratitis and fungal keratitisThe patent, already granted in Italy and EurAsian Countries, ensures IP protection until 2040AKANTIOR® will be commercially available in Germany from Oct. 1st View original content:https://www.prnewswire.co.uk/news-releases/sifi-announces-allowance-of-patent-on-polihexanide-for-europe-and-commercial-launch-of-akantior-in-germany-302260004.html
en | boerse | 67926694 |
